Skip to main content
Figure 5 | Arthritis Research & Therapy

Figure 5

From: Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

Figure 5

Levels of soluble receptor for advanced glycation end products (soluble RAGE) in blood and synovial fluids of rheumatoid arthritis (RA) patients who received methotrexate treatment or were not treated with disease-modifying antirheumatic drugs (DMARDs) at all. Box plots show the 25th and 75th percentiles. Horizontal lines in bold within boxes indicate medians, and dashed lines indicate means. Vertical bars indicate the 5th and 95th percentiles. Statistical differences with respect to soluble RAGE levels between groups were calculated using the Mann–Whitney U test. Mean ± standard error of the mean (median) values are shown. NS, not significant.

Back to article page